Weekly cabazitaxel in "unfit" metastatic castration resistant prostate cancer patients (mCRPC) progressing after docetaxel (D) treatment. CABASEM-SOGUG phase II trial

Anido Herranz, Urbano; Fernández Calvo, Ovidio; León Mateos, Luis Ángel

Statistics

Statistics

View Usage Statistics

Identifiers

Identifiers

URI: http://hdl.handle.net/20.500.11940/6314

DOI: 361887402246

ISSN: 0959-8049

Full record

Services

Services

RIS

Mendeley

Linksolver

Date issued

2015

Journal title

EUROPEAN JOURNAL OF CANCER

Type of content

Publicación de congreso